Cargando…
Orphan Drug Pricing and Costs: A Case Study of Kalydeco and Orkambi
BACKGROUND: A common narrative is that high prices are necessary for “orphan drugs” because of the fewer patients. In the context of state health insurance systems, the high prices create significant challenges because of limited budgets. RESULTS: This study carefully examines both costs and revenue...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Longwoods Publishing
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008693/ https://www.ncbi.nlm.nih.gov/pubmed/31629457 http://dx.doi.org/10.12927/hcpol.2019.25937 |